{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:43:29Z","timestamp":1790419409584,"version":"4.1.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion Medicine Reviews"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1016\/j.tmrv.2009.03.002","type":"journal-article","created":{"date-parts":[[2009,6,19]],"date-time":"2009-06-19T08:36:12Z","timestamp":1245400572000},"page":"189-204","source":"Crossref","is-referenced-by-count":32,"title":["Antigen Loss From Antibody-Coated Red Blood Cells"],"prefix":"10.1016","volume":"23","author":[{"given":"James C.","family":"Zimring","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantel M.","family":"Cadwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven L.","family":"Spitalnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tmrv.2009.03.002_bib1","series-title":"The blood group antigen facts book","author":"Reid","year":"2004"},{"key":"10.1016\/j.tmrv.2009.03.002_bib2","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/j.1537-2995.2008.02045.x","article-title":"An auto-anti-Kpb IgM that simulates antigen-suppression","volume":"49","author":"Bosco","year":"2009","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2009.03.002_bib3","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1423-0410.1972.tb03846.x","article-title":"Apparent depression of antigens of the Kell blood group system associated with autoimmune acquired haemolytic anaemia","volume":"23","author":"Seyfried","year":"1972","journal-title":"Vox Sang"},{"key":"10.1016\/j.tmrv.2009.03.002_bib4","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1046\/j.1537-2995.1979.19279160294.x","article-title":"Auto anti-Kpb associated with weakened antigenicity in the Kell blood group system: A second example","volume":"19","author":"Beck","year":"1979","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2009.03.002_bib5","first-page":"201","article-title":"Temporary reduction of red cell Kell system antigen expression and transient production of anti-Kpb in a surgical patient","volume":"2","author":"Brendel","year":"1985","journal-title":"Biotest Bull"},{"key":"10.1016\/j.tmrv.2009.03.002_bib6","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/ajh.2830070208","article-title":"Autoimmune hemolytic anemia and the Kell blood groups","volume":"7","author":"Marsh","year":"1979","journal-title":"Am J Hematol"},{"key":"10.1016\/j.tmrv.2009.03.002_bib7","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1365-2141.1987.tb02270.x","article-title":"Acquired loss of red cell Kell antigens","volume":"65","author":"Vengelen-Tyler","year":"1987","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2009.03.002_bib8","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/j.1365-2141.1994.tb06741.x","article-title":"Transient loss of proteins carrying Kell and Lutheran red cell antigens during consecutive relapses of autoimmune thrombocytopenia","volume":"87","author":"Williamson","year":"1994","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2009.03.002_bib9","first-page":"289","article-title":"Session on blood group substances and red cell membrane receptors","volume":"39","author":"Koscielak","year":"1980","journal-title":"Vox Sang"},{"key":"10.1016\/j.tmrv.2009.03.002_bib10","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1365-2141.1981.tb07240.x","article-title":"A negative direct antiglobulin test with strong IgG red cell autoantibodies present in the serum of a patient with autoimmune haemolytic anaemia","volume":"49","author":"van't Veer","year":"1981","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2009.03.002_bib11","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1365-2141.1982.tb03928.x","article-title":"Atypical presentation of acute phase, antibody-induced haemolytic anaemia in an infant","volume":"52","author":"Issitt","year":"1982","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2009.03.002_bib12","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/j.1365-2141.1983.tb07324.x","article-title":"Depression of Rh antigen expression in antibody-induced haemolytic anaemia","volume":"53","author":"Issitt","year":"1983","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2009.03.002_bib13","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1365-2141.1988.tb02411.x","article-title":"Auto-anti-Jka in Evans' syndrome with negative direct antiglobulin test","volume":"69","author":"Ganly","year":"1988","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2009.03.002_bib14","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1046\/j.1537-2995.1990.30190117630.x","article-title":"Temporary suppression of Kidd system antigen expression accompanied by transient production of anti-Jk3","volume":"30","author":"Issitt","year":"1990","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2009.03.002_bib15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1182\/blood-2007-01-065730","article-title":"Apparent nonhemolytic alloantibody-induced red-cell antigen loss from transfused erythrocytes","volume":"109","author":"Powers","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2009.03.002_bib16","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1046\/j.1537-2995.1987.27187121474.x","article-title":"A Ge-like autoantibody in the serum of a patient receiving gold therapy for rheumatoid arthritis","volume":"27","author":"Beattie","year":"1987","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2009.03.002_bib17","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1365-2141.1988.tb02520.x","article-title":"Transient reduction in erythrocyte membrane sialoglycoprotein beta associated with the presence of elliptocytes","volume":"70","author":"Daniels","year":"1988","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2009.03.002_bib18","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1537-2995.1971.tb04405.x","article-title":"Transient production of anti-LW by LW-positive people","volume":"11","author":"Chown","year":"1971","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2009.03.002_bib19","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1423-0410.1967.tb03784.x","article-title":"A complex serological investigation involving LW","volume":"13","author":"Giles","year":"1967","journal-title":"Vox Sang"},{"key":"10.1016\/j.tmrv.2009.03.002_bib20","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1423-0410.1977.tb04479.x","article-title":"Transient LW-negative red blood cells and anti-LW in a patient with Hodgkin's disease","volume":"33","author":"Perkins","year":"1977","journal-title":"Vox Sang"},{"key":"10.1016\/j.tmrv.2009.03.002_bib21","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1423-0410.1986.tb04889.x","article-title":"Acquired loss of red-cell Wj antigen in a patient with Hodgkin's disease","volume":"50","author":"Mannessier","year":"1986","journal-title":"Vox Sang"},{"key":"10.1016\/j.tmrv.2009.03.002_bib22","first-page":"S37","article-title":"Transient loss of Cromer antigens and anti-IFC in a patient with chronic lymphatic leukaemia","volume":"87","author":"Banks","year":"2004","journal-title":"Vox Sang"},{"key":"10.1016\/j.tmrv.2009.03.002_bib23","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1046\/j.1537-2995.2002.00214.x","article-title":"Acquired and transient RBC CD55 deficiency (Inab phenotype) and anti-IFC","volume":"42","author":"Matthes","year":"2002","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2009.03.002_bib24","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1111\/j.1537-2995.2006.00933.x","article-title":"Case report and literature review: Transient Inab phenotype and an agglutinating anti-IFC in a patient with a gastrointestinal problem","volume":"46","author":"Yazer","year":"2006","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2009.03.002_bib25","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1423-0410.2008.01066.x","article-title":"Cross-linking induces non-haemolytic antigen-loss from transfused red blood cells: A potential role for rheumatoid factor","volume":"95","author":"Cadwell","year":"2008","journal-title":"Vox Sang"},{"key":"10.1016\/j.tmrv.2009.03.002_bib26","doi-asserted-by":"crossref","first-page":"594a","DOI":"10.1182\/blood.V108.11.2096.2096","volume":"108","author":"Mack","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2009.03.002_bib27","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1423-0410.1990.tb05001.x","article-title":"Serological and immunochemical specificity of a human autoanti-Gerbich\u2013like antibody","volume":"58","author":"Poole","year":"1990","journal-title":"Vox Sang"},{"key":"10.1016\/j.tmrv.2009.03.002_bib28","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jim.2004.08.004","article-title":"Complement activation and C3b deposition on rituximab-opsonized cells substantially blocks binding of phycoerythrin-labeled anti-mouse IgG probes to rituximab","volume":"294","author":"Beum","year":"2004","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.tmrv.2009.03.002_bib29","first-page":"663","article-title":"The Jkb red cell antigen and gram-negative organisms (abstract)","volume":"19","author":"McGinniss","year":"1979","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2009.03.002_bib30","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1046\/j.1537-2995.1984.24184122557.x","article-title":"Acquisition of K:1-like antigen during terminal sepsis","volume":"24","author":"McGinniss","year":"1984","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2009.03.002_bib31","doi-asserted-by":"crossref","first-page":"40284035","DOI":"10.1182\/blood-2003-11-3929","article-title":"A single recombinant anti-RhD IgG prevents RhD immunization: Association of RhD-positive red blood cell clearance rate with polymorphisms in the FcgammaRIIA and FcgammaIIIA genes","volume":"103","author":"Miescher","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2009.03.002_bib32","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1182\/blood-2006-08-040139","article-title":"Mouse models of IgG- and IgM-mediated hemolysis","volume":"109","author":"Schirmer","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2009.03.002_bib33","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1111\/j.1537-2995.2006.00966.x","article-title":"The production of red blood cell alloantibodies in mice transfused with blood from transgenic Fyb-expressing mice","volume":"46","author":"Campbell-Lee","year":"2006","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2009.03.002_bib34","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1182\/blood-2005-03-1040","article-title":"Nonhemolytic antibody-induced loss of erythrocyte surface antigen","volume":"106","author":"Zimring","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2009.03.002_bib35","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1182\/blood-2007-04-083097","article-title":"Nonhemolytic antigen loss from red blood cells requires cooperative binding of multiple antibodies recognizing different epitopes","volume":"110","author":"Zimring","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2009.03.002_bib36","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1084\/jem.152.1.20","article-title":"Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte, and monocyte","volume":"152","author":"Fearon","year":"1980","journal-title":"J Exp Med"},{"key":"10.1016\/j.tmrv.2009.03.002_bib37","first-page":"55","article-title":"The immune-adherence phenomenon; a hypothetical role of erythrocytes in defence against bacteria and viruses","volume":"49","author":"Nelson","year":"1956","journal-title":"Proc R Soc Med"},{"key":"10.1016\/j.tmrv.2009.03.002_bib38","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1126\/science.118.3077.733","article-title":"The immune-adherence phenomenon; an immunologically specific reaction between microorganisms and erythrocytes leading to enhanced phagocytosis","volume":"118","author":"Nelson","year":"1953","journal-title":"Science"},{"key":"10.1016\/j.tmrv.2009.03.002_bib39","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.4049\/jimmunol.145.12.4198","article-title":"Evaluation of the mechanisms responsible for the reduction in erythrocyte complement receptors when immune complexes form in vivo in primates","volume":"145","author":"Cosio","year":"1990","journal-title":"J Immunol"},{"key":"10.1016\/j.tmrv.2009.03.002_bib40","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1172\/JCI110764","article-title":"Primate erythrocyte-immune complex-clearing mechanism","volume":"71","author":"Cornacoff","year":"1983","journal-title":"J Clin Invest"},{"key":"10.1016\/j.tmrv.2009.03.002_bib41","doi-asserted-by":"crossref","first-page":"4613","DOI":"10.4049\/jimmunol.144.12.4613","article-title":"A study of in vivo immune complex formation and clearance in man","volume":"144","author":"Davies","year":"1990","journal-title":"J Immunol"},{"key":"10.1016\/j.tmrv.2009.03.002_bib42","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0161-5890(99)00103-0","article-title":"How are immune complexes bound to the primate erythrocyte complement receptor transferred to acceptor phagocytic cells?","volume":"36","author":"Nardin","year":"1999","journal-title":"Mol Immunol"},{"key":"10.1016\/j.tmrv.2009.03.002_bib43","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1046\/j.1523-1755.2001.00476.x","article-title":"No complement receptor 1 stumps on podocytes in human glomerulopathies","volume":"59","author":"Moll","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.tmrv.2009.03.002_bib44","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1182\/blood.V68.3.752.752","article-title":"Monoclonal antibody T101 in T cell malignancies: A clinical, pharmacokinetic, and immunologic correlation","volume":"68","author":"Bertram","year":"1986","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2009.03.002_bib45","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1182\/blood.V66.4.961.961","article-title":"In vivo administration of lymphocyte-specific monoclonal antibodies in nonhuman primates: I. Effects of anti-T11 antibodies on the circulating T cell pool","volume":"66","author":"Letvin","year":"1985","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2009.03.002_bib46","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1182\/blood.V58.1.78.78","article-title":"In vivo effects of murine hybridoma monoclonal antibody in a patient with T-cell leukemia","volume":"58","author":"Miller","year":"1981","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2009.03.002_bib47","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0090-1229(88)90074-8","article-title":"Mechanisms of human CD5 modulation and capping induced by murine monoclonal antibody T101","volume":"47","author":"Shawler","year":"1988","journal-title":"Clin Immunol Immunopath"},{"key":"10.1016\/j.tmrv.2009.03.002_bib48","first-page":"5921","article-title":"Induction of in vitro and in vivo antigenic modulation by the anti-human T-cell monoclonal antibody T101","volume":"44","author":"Shawler","year":"1984","journal-title":"Cancer Res"},{"key":"10.1016\/j.tmrv.2009.03.002_bib49","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.4049\/jimmunol.172.5.3280","article-title":"Rituximab infusion promotes rapid complement depletion and acute CD20 loss in chronic lymphocytic leukemia","volume":"172","author":"Kennedy","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.tmrv.2009.03.002_bib50","doi-asserted-by":"crossref","first-page":"4263","DOI":"10.4049\/jimmunol.179.6.4263","article-title":"Rituximab-CD20 complexes are shaved from Z138 mantle cell lymphoma cells in intravenous and subcutaneous SCID mouse models","volume":"179","author":"Li","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.tmrv.2009.03.002_bib51","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.4049\/jimmunol.176.4.2600","article-title":"The shaving reaction: rituximab\/CD20 complexes are removed from mantle cell lymphoma and chronic lymphocytic leukemia cells by THP-1 monocytes","volume":"176","author":"Beum","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.tmrv.2009.03.002_bib52","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.4049\/jimmunol.181.4.2916","article-title":"Within peripheral blood mononuclear cells, antibody-dependent cellular cytotoxicity of rituximab-opsonized Daudi cells is promoted by NK cells and inhibited by monocytes due to shaving","volume":"181","author":"Beum","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.tmrv.2009.03.002_bib53","doi-asserted-by":"crossref","first-page":"8120","DOI":"10.4049\/jimmunol.181.11.8120","article-title":"Binding of rituximab, trastuzumab, cetuximab, or mAb T101 to cancer cells promotes trogocytosis mediated by THP-1 cells and monocytes","volume":"181","author":"Beum","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.tmrv.2009.03.002_bib54","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1084\/jem.144.3.788","article-title":"Studies on the mechanism of phagocytosis. II. The interaction of macrophages with anti-immunoglobulin IgG-coated bone marrow-derived lymphocytes","volume":"144","author":"Griffin","year":"1976","journal-title":"J Exp Med"},{"key":"10.1016\/j.tmrv.2009.03.002_bib55","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1182\/blood-2004-03-0896","article-title":"Anti-GPVI\u2013associated ITP: An acquired platelet disorder caused by autoantibody-mediated clearance of the GPVI\/FcRgamma-chain complex from the human platelet surface","volume":"104","author":"Boylan","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2009.03.002_bib56","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1084\/jem.20020945","article-title":"A crucial role of glycoprotein VI for platelet recruitment to the injured arterial wall in vivo","volume":"197","author":"Massberg","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.tmrv.2009.03.002_bib57","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1084\/jem.193.4.459","article-title":"Long-term antithrombotic protection by in vivo depletion of platelet glycoprotein VI in mice","volume":"193","author":"Nieswandt","year":"2001","journal-title":"J Exp Med"},{"key":"10.1016\/j.tmrv.2009.03.002_bib58","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1182\/blood-2002-10-3242","article-title":"Targeting of the collagen-binding site on glycoprotein VI is not essential for in vivo depletion of the receptor","volume":"101","author":"Schulte","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2009.03.002_bib59","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1002\/eji.1830220939","article-title":"Passive transfer of experimental myasthenia gravis via antigenic modulation of acetylcholine receptor","volume":"22","author":"Loutrari","year":"1992","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.tmrv.2009.03.002_bib60","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/0896-8411(89)90004-8","article-title":"Fab fragments of monoclonal antibodies protect the human acetylcholine receptor against antigenic modulation caused by myasthenic sera","volume":"2","author":"Sophianos","year":"1989","journal-title":"J Autoimmun"},{"key":"10.1016\/j.tmrv.2009.03.002_bib61","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.4049\/jimmunol.134.4.2343","article-title":"Role of the main immunogenic region of acetylcholine receptor in myasthenia gravis. An Fab monoclonal antibody protects against antigenic modulation by human sera","volume":"134","author":"Tzartos","year":"1985","journal-title":"J Immunol"},{"key":"10.1016\/j.tmrv.2009.03.002_bib62","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1126\/science.850793","article-title":"Myasthenic immunoglobulin accelerates acetylcholine receptor degradation","volume":"196","author":"Kao","year":"1977","journal-title":"Science"}],"container-title":["Transfusion Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887796309000285?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887796309000285?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T18:42:06Z","timestamp":1685040126000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887796309000285"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["S0887796309000285"],"URL":"https:\/\/doi.org\/10.1016\/j.tmrv.2009.03.002","relation":{},"ISSN":["0887-7963"],"issn-type":[{"value":"0887-7963","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}